Bank of Nova Scotia’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.4M Sell
47,759
-18,756
-28% -$1.48M 0.01% 659
2025
Q4
$5.46M Sell
66,515
-3,640
-5% -$284K 0.01% 605
2025
Q3
$5.27M Buy
70,155
+30,019
+75% +$2.24M 0.01% 542
2025
Q2
$2.97M Sell
40,136
-8,612
-18% -$600K 0.01% 602
2025
Q1
$3.93M Sell
48,748
-12,941
-21% -$1.11M 0.01% 505
2024
Q4
$4.82M Sell
61,689
-104,655
-63% -$8.9M 0.01% 532
2024
Q3
$15.6M Buy
166,344
+121,012
+267% +$10.2M 0.03% 274
2024
Q2
$3.53M Sell
45,332
-6,090
-12% -$497K 0.01% 528
2024
Q1
$4.68M Buy
51,422
+2,575
+5% +$214K 0.01% 517
2023
Q4
$3.78M Buy
48,847
+11,103
+29% +$778K 0.01% 550
2023
Q3
$2.57M Sell
37,744
-7,760
-17% -$565K 0.01% 526
2023
Q2
$3.7M Buy
45,504
+18,823
+71% +$1.5M 0.01% 417
2023
Q1
$2.19M Buy
+26,681
New +$1.91M 0.01% 518

Other funds holding GEHC

Bank of Nova Scotia's GEHC Position: Q1 2026 in Review

Bank of Nova Scotia reduced its GE HealthCare (GEHC) stake by 28% in Q1 2026, selling an estimated $1.48M and leaving 47,759 shares worth $3.4M. The position accounts for 0.01% of the portfolio, ranked #659.

Bank of Nova Scotia first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $15.6M in Q3 2024. 1,265 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Bank of Nova Scotia held 47,759 shares of GE HealthCare worth $3.4M as of Q1 2026.
  • Bank of Nova Scotia sold 18,756 GE HealthCare shares in Q1 2026, an estimated $1.48M.
  • GE HealthCare made up 0.01% of Bank of Nova Scotia's portfolio in Q1 2026, its #659 holding.
  • Bank of Nova Scotia first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Bank of Nova Scotia's GE HealthCare position peaked at $15.6M in Q3 2024.
  • 1,265 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Bank of Nova Scotia's 13F filing for Q1 2026, filed 14 May 2026.